Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function
about
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats.Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Oxytocin: the great facilitator of life.Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia.Towards medication-enhancement of cognitive interventions in schizophreniaAn Overview of the Association between Schizotypy and Dopamine.Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophreniaA Methionine-Induced Animal Model of Schizophrenia: Face and Predictive ValidityPrenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine.Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyReelin haploinsufficiency reduces the density of PV+ neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviorsImprovement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphismAssociation analysis of 94 candidate genes and schizophrenia-related endophenotypes.Structural brain correlates of sensorimotor gating in antipsychotic-naive men with first-episode schizophrenia.Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition.Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family HistoryMemantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersElectroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat.Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist.Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in ratsSensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.In Vivo Ca(2+) Imaging Reveals that Decreased Dendritic Excitability Drives Startle Habituation.Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometrySensorimotor gating, cannabis use and the risk of psychosisAcoustic prepulse inhibition: one ear is better than two, but why and when?Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS.Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patientsContrasting effect of prepulse signals on performance of Toxoplasma-infected and Toxoplasma-free subjects in an acoustic reaction times test.Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controlsUpdate: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats.Clonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication.Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses.Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.
P2860
Q21129280-D43789FC-136A-42A8-B072-9DB3579E93FCQ24603020-E9ED0D36-D26F-4CFC-98FB-292C3E51F82AQ24633622-26744A03-1A13-4E65-80F9-49C82119B1ABQ24645703-BCB98D75-0502-483B-B855-B77545317784Q24651638-AF3DB2C4-6B2A-4385-82F4-CB085970E54CQ26738436-6BD7B7EE-FDC3-4581-861A-44E22B7DB325Q26829347-29CA2C05-51C9-4A98-B73E-1A4B6864B2F5Q26860777-63185014-1AD6-4B79-91C3-06F06E9BDAC9Q26991569-65B8D13F-3DBE-45F9-AE9D-055F68805D6EQ27014120-8A49F032-B586-4518-8BEB-547AC9B9F3FCQ27300760-20C01C67-9938-4BDC-BB1E-DA6FC502E716Q27304814-EDA8E9D2-F6DE-4499-8056-6C43BEA30CFFQ28078534-A7550B13-AB88-4484-80F9-D3118C551723Q28237853-4B164E57-8A7B-4245-BF34-9E7D0321722CQ28282922-9A8D8B8B-9B32-46B5-9E9F-AECAB303606FQ28732827-0FCD72CF-3D56-4C10-8AEB-EBC59A248F7BQ29364530-72F70ACD-357D-417D-8F54-0DD9F60A3FECQ30358899-1574051F-C682-4737-88B1-9BCD75571661Q30359621-518E6433-A0B6-4EBE-ABE2-C2F7156CBB97Q30366961-80CE7857-099D-4A67-BE91-5284127F23FFQ30372351-6373F0E9-4BF4-42B7-9B1E-687DAB5E9070Q30374981-C7D93D73-98E1-4B42-BE06-EC085BAAFC75Q30375583-755EE5AC-7C5A-49B9-84E1-2DA5CC1AEB77Q30382547-F79E46C3-D5A4-4F4D-8E12-E629308C54B8Q30391389-667DED3A-9A7C-4953-8D1C-6BDC98A2C61FQ30392543-315D07AE-8844-4C3E-B510-229B6E78A0A6Q30394589-9B17343C-819F-40CC-BA7D-3B9D02414D50Q30395904-190E0536-4C18-47A1-8E8B-FF425B2CE3A7Q30404054-CD322128-74CB-4F7B-8B45-416EDCD7CCDFQ30411076-20EE46F7-EFEC-467F-8630-17C1DC4F0D0CQ30413595-5360978D-261E-4026-8F2D-47E553037F0EQ30419989-4EC59EB0-E38C-44B5-8D95-60C6D96FC100Q30425458-BDAD8440-809B-4FF3-B5DA-3D76EA92F2A4Q30426286-CD6F4380-E9F3-4240-AA4C-2BE77299A910Q30430004-7A16683A-49CA-47F0-B78F-E69D09013B92Q30435819-98EDE3E5-80C0-4F6F-92E6-67F3E0E2FCFEQ30437145-5125FBE1-B5DD-4956-AB65-352794657D77Q30439307-77701B87-00BE-4496-9AE0-FAEB858181E2Q30439826-361F8400-E116-406D-BB01-520AF92563C0Q30440988-6CE688F5-4201-411A-B634-3E3E2BEE0299
P2860
Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Startle gating deficits in a l ...... gnition, and level of function
@ast
Startle gating deficits in a l ...... gnition, and level of function
@en
Startle gating deficits in a l ...... gnition, and level of function
@nl
type
label
Startle gating deficits in a l ...... gnition, and level of function
@ast
Startle gating deficits in a l ...... gnition, and level of function
@en
Startle gating deficits in a l ...... gnition, and level of function
@nl
prefLabel
Startle gating deficits in a l ...... gnition, and level of function
@ast
Startle gating deficits in a l ...... gnition, and level of function
@en
Startle gating deficits in a l ...... gnition, and level of function
@nl
P2093
P3181
P1433
P1476
Startle gating deficits in a l ...... gnition, and level of function
@en
P2093
David L Braff
Gregory A Light
Joyce Sprock
Neal R Swerdlow
P304
P3181
P356
10.1001/ARCHPSYC.63.12.1325
P407
P577
2006-12-01T00:00:00Z